CICoach ImpactOS

Evidence Lab

Fish Oil / Omega-3

Fish oil supplies EPA and DHA omega-3 fatty acids. Athlete studies show some recovery and physiological signals, but performance benefits are inconsistent; dose decisions should consider diet, product quality and medical context.

Evidence rating: Emerging / Mixed

Published 8/14/2026 | Last reviewed 8/14/2026

Overview

Fish oil supplements provide the long-chain omega-3 fatty acids EPA and DHA. These fats have established biological roles and are widely studied for cardiovascular and inflammatory outcomes, but the question for athletes is whether supplementation adds meaningful performance or recovery benefit. A systematic review in athletes found some consistent effects on selected central-nervous-system, cardiovascular, inflammatory and skeletal-muscle outcomes, while finding no clear improvement in endurance performance, muscle force or training adaptation. A later meta-analysis in healthy adults found a very small effect on muscle strength but no meaningful effect on muscle mass or function. The practical decision should therefore start with dietary intake and purpose. People who rarely eat oily fish may use an EPA/DHA supplement to increase marine omega-3 intake, but that is different from claiming that fish oil is a reliable ergogenic aid.

Common use

To increase EPA and DHA intake when dietary intake is low; possible recovery support is secondary and not a guaranteed performance effect.

Common forms

Fish-oil softgels or liquids, concentrated EPA/DHA products and algal EPA/DHA alternatives. Compare products by actual EPA plus DHA, not total fish-oil weight.

Practical notes

Check the EPA and DHA amounts per serving and use reputable products with oxidation and contamination controls. A large capsule weight does not necessarily mean a large EPA+DHA dose. Last evidence review: 14 August 2026.

Claim-level evidence

Emerging / Mixed

Fish oil may influence selected recovery, inflammatory and neuromuscular outcomes, but athlete-performance effects are inconsistent.

Population: Healthy athletes and active adults.

Do not present fish oil as a reliable performance enhancer.

Limitations: Athlete trials are heterogeneous and systematic reviews report no clear improvement in endurance performance, muscle force or training adaptation.

Emerging / Mixed

Omega-3 supplementation has at most a very small average effect on muscle strength and no clear effect on muscle mass or function in healthy adults.

Population: Healthy younger and older adults.

Any muscle benefit appears small relative to training, protein and energy intake.

Limitations: Studies vary in age, dose, training and baseline omega-3 intake.

Strong

EPA and DHA intake can be increased through food or supplements; supplement labels should be judged by EPA+DHA content.

Population: Adults considering marine omega-3 intake.

Oily fish remains a food-based option; supplements are a concentrated alternative.

Limitations: This is nutritional context, not an athlete-specific performance claim.

Dosing context

  • Athlete/recovery research - Trials use varied EPA+DHA doses; there is no single established sports-performance dose. - With meals can improve tolerance; timing around a workout is not clearly important. - Usually chronic rather than acute.Choose dose by nutritional or clinical purpose rather than copying the highest sport-study dose.
  • Safety ceiling context - FDA and EFSA assessments summarized by NIH ODS indicate that supplements providing up to 5 g/day EPA+DHA appear safe for most adults when used as recommended. - Across the day with food if preferred. - Ongoing only when appropriate.This is a safety assessment, not a target dose. Lower intakes are commonly used, and medical context matters.

Safety notes

  • Anticoagulant or antiplatelet therapyHigh-dose omega-3s have antiplatelet effects. People using anticoagulant or antiplatelet medication should discuss supplemental EPA/DHA with the treating clinician.
  • Atrial fibrillation risk at high dosesSome long-term trials using 4 g/day omega-3 in people with cardiovascular disease or high cardiovascular risk found a small increase in atrial fibrillation. Do not generalize high-dose protocols to healthy athletes.
  • Gastrointestinal effects and product qualityFishy taste, reflux, nausea or diarrhea can occur. Choose products with transparent EPA/DHA content and appropriate contaminant and oxidation quality control.

Interactions

  • Anticoagulant and antiplatelet medicinesDiscuss higher-dose EPA/DHA with the prescribing clinician because of potential effects on bleeding risk and treatment monitoring.
  • High cardiovascular-risk or atrial-fibrillation historyHigh-dose omega-3 supplementation requires medical context; it should not be self-prescribed as a sports supplement.

References

  1. NIH Office of Dietary Supplements. Omega-3 Fatty Acids - Health Professional Fact Sheet National Institutes of Health. 2026.Source
  2. Lewis NA, Daniels D, Calder PC, Castell LM, Pedlar CR. Are There Benefits from the Use of Fish Oil Supplements in Athletes? A Systematic Review Advances in Nutrition. 2020.Source
  3. Santo André HC, Esteves GP, Barreto GHC, et al.. The Influence of n-3PUFA Supplementation on Muscle Strength, Mass, and Function: A Systematic Review and Meta-Analysis Advances in Nutrition. 2023.Source